<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00793559</url>
  </required_header>
  <id_info>
    <org_study_id>161/08</org_study_id>
    <nct_id>NCT00793559</nct_id>
  </id_info>
  <brief_title>Terlipressin Administration in Septic Shock Refractory to Catecholamines</brief_title>
  <official_title>Terlipressin Administration in Septic Shock Refractory to Catecholamines Bolus vs. Continuous Drip-Phase II</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assaf-Harofeh Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assaf-Harofeh Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      terlipressin is given to refractory septic shock patients who do not respond to noradrenalin
      in Israel and Europe. It is given by bolus injection. we attempt to investigate weather it is
      better to give it by continuous drip and avoid abrupt changes in BP and heart function
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2008</start_date>
  <completion_date type="Anticipated">July 2009</completion_date>
  <primary_completion_date type="Anticipated">July 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CI, SVR,HR,BP, noradrenalin administration,renal function</measure>
    <time_frame>6 mo</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>terlipressin bolus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 mg of terlipressin received one time only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>terlipressin drip</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>terlipressin</intervention_name>
    <description>1 mg of terlipressin one time only</description>
    <arm_group_label>terlipressin bolus</arm_group_label>
    <other_name>glypressin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>terlipressin</intervention_name>
    <description>1 mg of terlipressin in 50 cc of NS given at a drip of a total of 6 h</description>
    <arm_group_label>terlipressin drip</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  septic shock patients receiving above 0.5 mcg/kg NA

        Exclusion Criteria:

          -  allergy to terlipressin, CHF, IHD, pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tal Mann, Dr</last_name>
    <role>Study Director</role>
    <affiliation>Asaf Harofeh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tal Mann, Dr</last_name>
    <phone>97257345789</phone>
    <email>tal_mb@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Asaf Harofeh MC</name>
      <address>
        <city>Zrifin</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2008</study_first_submitted>
  <study_first_submitted_qc>November 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2008</study_first_posted>
  <last_update_submitted>November 18, 2008</last_update_submitted>
  <last_update_submitted_qc>November 18, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr Yuval Leonov</name_title>
    <organization>Assaf-Harofeh Medical Center</organization>
  </responsible_party>
  <keyword>septic shock refractory to catecholamines</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Terlipressin</mesh_term>
    <mesh_term>Lypressin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

